

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | base-excision repair, AP site formation (GO:0006285) | 5.98099949 |
| 2 | pyrimidine deoxyribonucleotide catabolic process (GO:0009223) | 5.81200678 |
| 3 | sequestering of actin monomers (GO:0042989) | 5.20094233 |
| 4 | ribosomal small subunit assembly (GO:0000028) | 5.18138756 |
| 5 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 5.13500145 |
| 6 | endothelium development (GO:0003158) | 4.94646890 |
| 7 | protein neddylation (GO:0045116) | 4.88090155 |
| 8 | pyrimidine nucleotide catabolic process (GO:0006244) | 4.83125309 |
| 9 | thrombin receptor signaling pathway (GO:0070493) | 4.74468833 |
| 10 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 4.72912714 |
| 11 | deoxyribonucleotide catabolic process (GO:0009264) | 4.35798435 |
| 12 | seminiferous tubule development (GO:0072520) | 4.14716555 |
| 13 | ATP synthesis coupled proton transport (GO:0015986) | 4.12684437 |
| 14 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 4.12684437 |
| 15 | regulation of transmission of nerve impulse (GO:0051969) | 4.12482219 |
| 16 | pyrimidine deoxyribonucleotide metabolic process (GO:0009219) | 4.11399911 |
| 17 | deoxyribose phosphate catabolic process (GO:0046386) | 4.10099776 |
| 18 | aggressive behavior (GO:0002118) | 3.90959052 |
| 19 | phospholipase C-activating dopamine receptor signaling pathway (GO:0060158) | 3.87846668 |
| 20 | viral transcription (GO:0019083) | 3.78393548 |
| 21 | polyketide metabolic process (GO:0030638) | 3.69103521 |
| 22 | doxorubicin metabolic process (GO:0044598) | 3.69103521 |
| 23 | daunorubicin metabolic process (GO:0044597) | 3.69103521 |
| 24 | protein complex biogenesis (GO:0070271) | 3.68821307 |
| 25 | translational termination (GO:0006415) | 3.66316104 |
| 26 | GPI anchor biosynthetic process (GO:0006506) | 3.65588742 |
| 27 | positive regulation of B cell differentiation (GO:0045579) | 3.63060174 |
| 28 | platelet dense granule organization (GO:0060155) | 3.51640073 |
| 29 | definitive hemopoiesis (GO:0060216) | 3.45605819 |
| 30 | mannosylation (GO:0097502) | 3.45320652 |
| 31 | negative regulation of B cell apoptotic process (GO:0002903) | 3.44978836 |
| 32 | purine deoxyribonucleotide catabolic process (GO:0009155) | 3.41407173 |
| 33 | mitochondrial respiratory chain complex assembly (GO:0033108) | 3.35269628 |
| 34 | epithelial cell differentiation involved in kidney development (GO:0035850) | 3.34206865 |
| 35 | aminoglycoside antibiotic metabolic process (GO:0030647) | 3.32115378 |
| 36 | 2-deoxyribonucleotide metabolic process (GO:0009394) | 3.30694552 |
| 37 | mitochondrial respiratory chain complex I biogenesis (GO:0097031) | 3.23616765 |
| 38 | mitochondrial respiratory chain complex I assembly (GO:0032981) | 3.23616765 |
| 39 | NADH dehydrogenase complex assembly (GO:0010257) | 3.23616765 |
| 40 | GPI anchor metabolic process (GO:0006505) | 3.21678339 |
| 41 | purinergic nucleotide receptor signaling pathway (GO:0035590) | 3.19692751 |
| 42 | galactose catabolic process (GO:0019388) | 3.18698212 |
| 43 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 3.17928712 |
| 44 | C-terminal protein lipidation (GO:0006501) | 3.15229144 |
| 45 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 3.13917792 |
| 46 | low-density lipoprotein particle remodeling (GO:0034374) | 3.12626767 |
| 47 | deoxyribose phosphate metabolic process (GO:0019692) | 3.11605412 |
| 48 | cell differentiation involved in metanephros development (GO:0072202) | 3.10336847 |
| 49 | translational elongation (GO:0006414) | 3.10042780 |
| 50 | cotranslational protein targeting to membrane (GO:0006613) | 3.09621822 |
| 51 | relaxation of smooth muscle (GO:0044557) | 3.08263580 |
| 52 | preassembly of GPI anchor in ER membrane (GO:0016254) | 3.05270602 |
| 53 | protein targeting to ER (GO:0045047) | 3.04655858 |
| 54 | protein localization to endoplasmic reticulum (GO:0070972) | 2.99765402 |
| 55 | purine-containing compound salvage (GO:0043101) | 2.99548852 |
| 56 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 2.99040708 |
| 57 | defense response to protozoan (GO:0042832) | 2.97157703 |
| 58 | activation of transmembrane receptor protein tyrosine kinase activity (GO:0007171) | 2.97074448 |
| 59 | L-ascorbic acid metabolic process (GO:0019852) | 2.96963815 |
| 60 | high-density lipoprotein particle remodeling (GO:0034375) | 2.95354698 |
| 61 | negative regulation of nitric oxide biosynthetic process (GO:0045019) | 2.94780853 |
| 62 | respiratory electron transport chain (GO:0022904) | 2.94670705 |
| 63 | electron transport chain (GO:0022900) | 2.93479672 |
| 64 | inner mitochondrial membrane organization (GO:0007007) | 2.92919829 |
| 65 | negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315) | 2.89890530 |
| 66 | urinary tract smooth muscle contraction (GO:0014848) | 2.88673178 |
| 67 | purine nucleotide salvage (GO:0032261) | 2.88060396 |
| 68 | negative regulation of synaptic transmission, glutamatergic (GO:0051967) | 2.87153252 |
| 69 | establishment of protein localization to endoplasmic reticulum (GO:0072599) | 2.86991240 |
| 70 | tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388) | 2.85319916 |
| 71 | RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394) | 2.85319916 |
| 72 | establishment of protein localization to mitochondrial membrane (GO:0090151) | 2.82710103 |
| 73 | positive regulation of vasculogenesis (GO:2001214) | 2.82482164 |
| 74 | oxidative phosphorylation (GO:0006119) | 2.82436366 |
| 75 | cellular response to interferon-beta (GO:0035458) | 2.81063323 |
| 76 | viral life cycle (GO:0019058) | 2.80293395 |
| 77 | monoamine transport (GO:0015844) | 2.78980510 |
| 78 | angiogenesis involved in wound healing (GO:0060055) | 2.77886498 |
| 79 | artery smooth muscle contraction (GO:0014824) | 2.77167419 |
| 80 | blood vessel maturation (GO:0001955) | 2.76087974 |
| 81 | adult feeding behavior (GO:0008343) | 2.76039396 |
| 82 | cellular protein complex disassembly (GO:0043624) | 2.74672491 |
| 83 | response to protozoan (GO:0001562) | 2.74617235 |
| 84 | axoneme assembly (GO:0035082) | 2.73774711 |
| 85 | regulation of cholesterol esterification (GO:0010872) | 2.73727830 |
| 86 | response to interferon-beta (GO:0035456) | 2.72055428 |
| 87 | GMP metabolic process (GO:0046037) | 2.71554879 |
| 88 | valine metabolic process (GO:0006573) | 2.71191503 |
| 89 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 2.70208454 |
| 90 | L-phenylalanine catabolic process (GO:0006559) | 2.70208454 |
| 91 | regulation of dopamine metabolic process (GO:0042053) | 2.66961371 |
| 92 | regulation of catecholamine metabolic process (GO:0042069) | 2.66961371 |
| 93 | negative regulation of response to food (GO:0032096) | 2.65599453 |
| 94 | negative regulation of appetite (GO:0032099) | 2.65599453 |
| 95 | purine deoxyribonucleotide metabolic process (GO:0009151) | 2.65121448 |
| 96 | regulation of mast cell degranulation (GO:0043304) | 2.64120565 |
| 97 | reverse cholesterol transport (GO:0043691) | 2.62893801 |
| 98 | behavioral response to cocaine (GO:0048148) | 2.61994030 |
| 99 | deoxyribonucleotide metabolic process (GO:0009262) | 2.61731814 |
| 100 | neutrophil activation involved in immune response (GO:0002283) | 2.60679193 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 6.01383553 |
| 2 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 5.15027695 |
| 3 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 3.78170455 |
| 4 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 3.51418611 |
| 5 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 2.89755292 |
| 6 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.79869987 |
| 7 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 2.79813245 |
| 8 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.73548815 |
| 9 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.70027112 |
| 10 | IGF1R_20145208_ChIP-Seq_DFB_Human | 2.48954731 |
| 11 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 2.41338455 |
| 12 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 2.38766481 |
| 13 | ZNF274_21170338_ChIP-Seq_K562_Hela | 2.29365858 |
| 14 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 2.19866061 |
| 15 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 2.14413573 |
| 16 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 2.12585488 |
| 17 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 2.06392279 |
| 18 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.00188766 |
| 19 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.99105963 |
| 20 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.95568870 |
| 21 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 1.95515218 |
| 22 | EZH2_22144423_ChIP-Seq_EOC_Human | 1.94671537 |
| 23 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.93753821 |
| 24 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.92421083 |
| 25 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 1.91299006 |
| 26 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.86272173 |
| 27 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.85186136 |
| 28 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.76111928 |
| 29 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.72019745 |
| 30 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.70526520 |
| 31 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.70388865 |
| 32 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.68703142 |
| 33 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.66682205 |
| 34 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.65244127 |
| 35 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.62245398 |
| 36 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.61105201 |
| 37 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 1.54314241 |
| 38 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 1.54230309 |
| 39 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.50238702 |
| 40 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.49127600 |
| 41 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.47447255 |
| 42 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.47033945 |
| 43 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.46982328 |
| 44 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.44581577 |
| 45 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.40820386 |
| 46 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.40732487 |
| 47 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.38831369 |
| 48 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.35168827 |
| 49 | P300_27268052_Chip-Seq_Bcells_Human | 1.33206699 |
| 50 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.29718589 |
| 51 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.29038483 |
| 52 | TP53_22573176_ChIP-Seq_HFKS_Human | 1.27553223 |
| 53 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 1.27077570 |
| 54 | GATA1_19941826_ChIP-Seq_K562_Human | 1.27066615 |
| 55 | SPI1_20517297_ChIP-Seq_HL60_Human | 1.26940552 |
| 56 | MYC_18940864_ChIP-ChIP_HL60_Human | 1.26876964 |
| 57 | AR_20517297_ChIP-Seq_VCAP_Human | 1.25371501 |
| 58 | FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.23560173 |
| 59 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.21862253 |
| 60 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.20664047 |
| 61 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.19695310 |
| 62 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 1.17214950 |
| 63 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.14755852 |
| 64 | E2F1_20622854_ChIP-Seq_HELA_Human | 1.12325280 |
| 65 | STAT1_20625510_ChIP-Seq_HELA_Human | 1.12161668 |
| 66 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 1.11366196 |
| 67 | PHF8_20622854_ChIP-Seq_HELA_Human | 1.08678482 |
| 68 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.07865980 |
| 69 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.07704719 |
| 70 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.07497468 |
| 71 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.06081281 |
| 72 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.05403869 |
| 73 | GATA1_22025678_ChIP-Seq_K562_Human | 1.02091200 |
| 74 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.02008110 |
| 75 | RBPJ_21746931_ChIP-Seq_IB4-LCL_Human | 1.01971668 |
| 76 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.01107593 |
| 77 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 1.00441850 |
| 78 | NANOG_20526341_ChIP-Seq_ESCs_Human | 0.99801491 |
| 79 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 0.99185264 |
| 80 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 0.97980545 |
| 81 | TTF2_22483619_ChIP-Seq_HELA_Human | 0.97268361 |
| 82 | GATA3_21878914_ChIP-Seq_MCF-7_Human | 0.95981072 |
| 83 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 0.94502606 |
| 84 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.92849005 |
| 85 | GABP_19822575_ChIP-Seq_HepG2_Human | 0.91486487 |
| 86 | CTCF_18555785_ChIP-Seq_MESCs_Mouse | 0.90187892 |
| 87 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.88925265 |
| 88 | NANOG_19829295_ChIP-Seq_ESCs_Human | 0.88639802 |
| 89 | SOX2_19829295_ChIP-Seq_ESCs_Human | 0.88639802 |
| 90 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 0.88503931 |
| 91 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 0.86987494 |
| 92 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 0.86987494 |
| 93 | ERG_20517297_ChIP-Seq_VCAP_Human | 0.86583284 |
| 94 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 0.86490733 |
| 95 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 0.86369747 |
| 96 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.86363893 |
| 97 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 0.86005390 |
| 98 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 0.85183177 |
| 99 | MYC_19829295_ChIP-Seq_ESCs_Human | 0.83701151 |
| 100 | ELK1_19687146_ChIP-ChIP_HELA_Human | 0.83212431 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005464_abnormal_platelet_physiology | 3.99524958 |
| 2 | MP0001545_abnormal_hematopoietic_system | 3.71608261 |
| 3 | MP0005397_hematopoietic_system_phenotyp | 3.71608261 |
| 4 | MP0000465_gastrointestinal_hemorrhage | 3.39179912 |
| 5 | MP0009697_abnormal_copulation | 3.03543066 |
| 6 | MP0005646_abnormal_pituitary_gland | 2.95578152 |
| 7 | MP0009278_abnormal_bone_marrow | 2.91623805 |
| 8 | MP0009379_abnormal_foot_pigmentation | 2.49379525 |
| 9 | MP0001968_abnormal_touch/_nociception | 2.43990929 |
| 10 | MP0005084_abnormal_gallbladder_morpholo | 2.41376642 |
| 11 | MP0008872_abnormal_physiological_respon | 2.38189935 |
| 12 | MP0002653_abnormal_ependyma_morphology | 2.34274207 |
| 13 | MP0003880_abnormal_central_pattern | 2.24653297 |
| 14 | MP0005645_abnormal_hypothalamus_physiol | 2.16352510 |
| 15 | MP0006292_abnormal_olfactory_placode | 2.10400251 |
| 16 | MP0002102_abnormal_ear_morphology | 2.09635045 |
| 17 | MP0002148_abnormal_hypersensitivity_rea | 2.01155066 |
| 18 | MP0002822_catalepsy | 1.98315952 |
| 19 | MP0006276_abnormal_autonomic_nervous | 1.92159226 |
| 20 | MP0008058_abnormal_DNA_repair | 1.87046524 |
| 21 | MP0006036_abnormal_mitochondrial_physio | 1.83425990 |
| 22 | MP0000566_synostosis | 1.77792665 |
| 23 | MP0001986_abnormal_taste_sensitivity | 1.68370039 |
| 24 | MP0002132_abnormal_respiratory_system | 1.66135656 |
| 25 | MP0003186_abnormal_redox_activity | 1.61102464 |
| 26 | MP0008004_abnormal_stomach_pH | 1.59997675 |
| 27 | MP0002736_abnormal_nociception_after | 1.59050408 |
| 28 | MP0005410_abnormal_fertilization | 1.58250461 |
| 29 | MP0003315_abnormal_perineum_morphology | 1.57149206 |
| 30 | MP0001835_abnormal_antigen_presentation | 1.54688136 |
| 31 | MP0009765_abnormal_xenobiotic_induced | 1.48126078 |
| 32 | MP0003191_abnormal_cellular_cholesterol | 1.46677952 |
| 33 | MP0003638_abnormal_response/metabolism_ | 1.39698233 |
| 34 | MP0001879_abnormal_lymphatic_vessel | 1.38016276 |
| 35 | MP0002638_abnormal_pupillary_reflex | 1.37341255 |
| 36 | MP0005394_taste/olfaction_phenotype | 1.35980145 |
| 37 | MP0005499_abnormal_olfactory_system | 1.35980145 |
| 38 | MP0008789_abnormal_olfactory_epithelium | 1.34813497 |
| 39 | MP0003724_increased_susceptibility_to | 1.34354656 |
| 40 | MP0003806_abnormal_nucleotide_metabolis | 1.33703336 |
| 41 | MP0000372_irregular_coat_pigmentation | 1.30199253 |
| 42 | MP0001905_abnormal_dopamine_level | 1.29659272 |
| 43 | MP0006072_abnormal_retinal_apoptosis | 1.27515707 |
| 44 | MP0002733_abnormal_thermal_nociception | 1.20306104 |
| 45 | MP0010030_abnormal_orbit_morphology | 1.19425655 |
| 46 | MP0000230_abnormal_systemic_arterial | 1.18705726 |
| 47 | MP0010386_abnormal_urinary_bladder | 1.17335964 |
| 48 | MP0001764_abnormal_homeostasis | 1.13535063 |
| 49 | MP0005165_increased_susceptibility_to | 1.13173579 |
| 50 | MP0001529_abnormal_vocalization | 1.12933833 |
| 51 | MP0005075_abnormal_melanosome_morpholog | 1.11844335 |
| 52 | MP0003718_maternal_effect | 1.07915821 |
| 53 | MP0000383_abnormal_hair_follicle | 1.06006040 |
| 54 | MP0003122_maternal_imprinting | 1.03271414 |
| 55 | MP0009333_abnormal_splenocyte_physiolog | 1.01363679 |
| 56 | MP0008873_increased_physiological_sensi | 0.98576594 |
| 57 | MP0002735_abnormal_chemical_nociception | 0.98156917 |
| 58 | MP0002282_abnormal_trachea_morphology | 0.97646605 |
| 59 | MP0005670_abnormal_white_adipose | 0.97290421 |
| 60 | MP0004885_abnormal_endolymph | 0.97117303 |
| 61 | MP0005551_abnormal_eye_electrophysiolog | 0.96203179 |
| 62 | MP0005535_abnormal_body_temperature | 0.93315018 |
| 63 | MP0004808_abnormal_hematopoietic_stem | 0.90320995 |
| 64 | MP0005167_abnormal_blood-brain_barrier | 0.89418821 |
| 65 | MP0009763_increased_sensitivity_to | 0.89216340 |
| 66 | MP0009840_abnormal_foam_cell | 0.85533133 |
| 67 | MP0008569_lethality_at_weaning | 0.85530355 |
| 68 | MP0008874_decreased_physiological_sensi | 0.85485056 |
| 69 | MP0010368_abnormal_lymphatic_system | 0.84234018 |
| 70 | MP0001756_abnormal_urination | 0.84057563 |
| 71 | MP0002019_abnormal_tumor_incidence | 0.83735588 |
| 72 | MP0004142_abnormal_muscle_tone | 0.83004678 |
| 73 | MP0004147_increased_porphyrin_level | 0.82070284 |
| 74 | MP0009643_abnormal_urine_homeostasis | 0.81604996 |
| 75 | MP0009046_muscle_twitch | 0.79744107 |
| 76 | MP0005000_abnormal_immune_tolerance | 0.78858581 |
| 77 | MP0008995_early_reproductive_senescence | 0.78041394 |
| 78 | MP0004133_heterotaxia | 0.77816168 |
| 79 | MP0005174_abnormal_tail_pigmentation | 0.77796576 |
| 80 | MP0002160_abnormal_reproductive_system | 0.77661462 |
| 81 | MP0008775_abnormal_heart_ventricle | 0.76443153 |
| 82 | MP0000631_abnormal_neuroendocrine_gland | 0.75912118 |
| 83 | MP0002938_white_spotting | 0.74034132 |
| 84 | MP0000516_abnormal_urinary_system | 0.73164207 |
| 85 | MP0005367_renal/urinary_system_phenotyp | 0.73164207 |
| 86 | MP0001970_abnormal_pain_threshold | 0.72815804 |
| 87 | MP0002557_abnormal_social/conspecific_i | 0.72301749 |
| 88 | MP0006035_abnormal_mitochondrial_morpho | 0.70812206 |
| 89 | MP0002067_abnormal_sensory_capabilities | 0.68558746 |
| 90 | MP0002272_abnormal_nervous_system | 0.68003444 |
| 91 | MP0009764_decreased_sensitivity_to | 0.67684997 |
| 92 | MP0005025_abnormal_response_to | 0.67058018 |
| 93 | MP0005085_abnormal_gallbladder_physiolo | 0.65653487 |
| 94 | MP0002398_abnormal_bone_marrow | 0.65333770 |
| 95 | MP0003075_altered_response_to | 0.63352600 |
| 96 | MP0001664_abnormal_digestion | 0.61654724 |
| 97 | MP0005220_abnormal_exocrine_pancreas | 0.61236284 |
| 98 | MP0002069_abnormal_eating/drinking_beha | 0.60940455 |
| 99 | MP0002572_abnormal_emotion/affect_behav | 0.60669799 |
| 100 | MP0000343_altered_response_to | 0.60358286 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Reticulocytopenia (HP:0001896) | 4.98695325 |
| 2 | Hepatocellular necrosis (HP:0001404) | 4.62060033 |
| 3 | Renal Fanconi syndrome (HP:0001994) | 4.48818104 |
| 4 | Hepatic necrosis (HP:0002605) | 4.06946377 |
| 5 | Increased intramyocellular lipid droplets (HP:0012240) | 3.90783472 |
| 6 | Petechiae (HP:0000967) | 3.77523163 |
| 7 | Increased hepatocellular lipid droplets (HP:0006565) | 3.70577145 |
| 8 | Mitochondrial inheritance (HP:0001427) | 3.63545704 |
| 9 | Abnormal pupillary function (HP:0007686) | 3.49532999 |
| 10 | Lipid accumulation in hepatocytes (HP:0006561) | 3.44216515 |
| 11 | Abnormality of lateral ventricle (HP:0030047) | 3.40957721 |
| 12 | Increased muscle lipid content (HP:0009058) | 3.39524587 |
| 13 | Prolonged bleeding time (HP:0003010) | 3.34747637 |
| 14 | Abnormal number of erythroid precursors (HP:0012131) | 3.29430591 |
| 15 | Reduced antithrombin III activity (HP:0001976) | 3.18708459 |
| 16 | 3-Methylglutaconic aciduria (HP:0003535) | 3.15334672 |
| 17 | Thrombocytosis (HP:0001894) | 3.09107766 |
| 18 | Myokymia (HP:0002411) | 3.08311125 |
| 19 | Emotional lability (HP:0000712) | 3.07901897 |
| 20 | Type I transferrin isoform profile (HP:0003642) | 3.06525567 |
| 21 | Exertional dyspnea (HP:0002875) | 3.04384440 |
| 22 | Increased CSF lactate (HP:0002490) | 2.99443287 |
| 23 | Dicarboxylic aciduria (HP:0003215) | 2.95300487 |
| 24 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.95300487 |
| 25 | Abnormality of cells of the erythroid lineage (HP:0012130) | 2.90990385 |
| 26 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 2.89628829 |
| 27 | Opisthotonus (HP:0002179) | 2.86997689 |
| 28 | Epistaxis (HP:0000421) | 2.86624737 |
| 29 | Pancreatic fibrosis (HP:0100732) | 2.77063964 |
| 30 | Abnormal mitochondria in muscle tissue (HP:0008316) | 2.75976252 |
| 31 | Abnormality of renal resorption (HP:0011038) | 2.71917412 |
| 32 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.70878729 |
| 33 | Abnormal protein glycosylation (HP:0012346) | 2.69768030 |
| 34 | Abnormal glycosylation (HP:0012345) | 2.69768030 |
| 35 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 2.69768030 |
| 36 | Abnormal protein N-linked glycosylation (HP:0012347) | 2.69768030 |
| 37 | Dyschromatopsia (HP:0007641) | 2.60741018 |
| 38 | Macrocytic anemia (HP:0001972) | 2.59148136 |
| 39 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 2.58717729 |
| 40 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 2.58717729 |
| 41 | Stenosis of the external auditory canal (HP:0000402) | 2.58605268 |
| 42 | Agammaglobulinemia (HP:0004432) | 2.54758310 |
| 43 | Hepatosplenomegaly (HP:0001433) | 2.53796182 |
| 44 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 2.53005811 |
| 45 | Pancreatic cysts (HP:0001737) | 2.52275418 |
| 46 | Decreased central vision (HP:0007663) | 2.52182370 |
| 47 | True hermaphroditism (HP:0010459) | 2.46038992 |
| 48 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 2.44855977 |
| 49 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.43594408 |
| 50 | Abnormality of midbrain morphology (HP:0002418) | 2.41936297 |
| 51 | Molar tooth sign on MRI (HP:0002419) | 2.41936297 |
| 52 | Microvesicular hepatic steatosis (HP:0001414) | 2.39132840 |
| 53 | Nephronophthisis (HP:0000090) | 2.34179668 |
| 54 | Optic disc pallor (HP:0000543) | 2.33508037 |
| 55 | Severe visual impairment (HP:0001141) | 2.33227527 |
| 56 | Rimmed vacuoles (HP:0003805) | 2.31523117 |
| 57 | Absent thumb (HP:0009777) | 2.27713059 |
| 58 | Central scotoma (HP:0000603) | 2.27264562 |
| 59 | Acute necrotizing encephalopathy (HP:0006965) | 2.26849791 |
| 60 | Abnormality of the prostate (HP:0008775) | 2.26398570 |
| 61 | Gingival bleeding (HP:0000225) | 2.25864752 |
| 62 | Stomatitis (HP:0010280) | 2.20127273 |
| 63 | Rhabdomyolysis (HP:0003201) | 2.18777173 |
| 64 | Exercise intolerance (HP:0003546) | 2.17242605 |
| 65 | Hyperlipoproteinemia (HP:0010980) | 2.16387544 |
| 66 | Hypothermia (HP:0002045) | 2.15433830 |
| 67 | Spontaneous abortion (HP:0005268) | 2.14337409 |
| 68 | Tubulointerstitial nephritis (HP:0001970) | 2.14103152 |
| 69 | Cystic liver disease (HP:0006706) | 2.13886899 |
| 70 | Hyperphosphaturia (HP:0003109) | 2.10194561 |
| 71 | Abnormality of DNA repair (HP:0003254) | 2.09266543 |
| 72 | Menorrhagia (HP:0000132) | 2.08283819 |
| 73 | Bile duct proliferation (HP:0001408) | 2.01328524 |
| 74 | Abnormal biliary tract physiology (HP:0012439) | 2.01328524 |
| 75 | Acute encephalopathy (HP:0006846) | 1.99667947 |
| 76 | Abnormality of pyrimidine metabolism (HP:0004353) | 1.97197670 |
| 77 | Colon cancer (HP:0003003) | 1.95414600 |
| 78 | Fatigue (HP:0012378) | 1.94630012 |
| 79 | Occipital encephalocele (HP:0002085) | 1.91719783 |
| 80 | Increased serum lactate (HP:0002151) | 1.89993442 |
| 81 | Paralysis (HP:0003470) | 1.89942701 |
| 82 | Flattened epiphyses (HP:0003071) | 1.88107449 |
| 83 | Cerebellar dysplasia (HP:0007033) | 1.82620410 |
| 84 | Abnormality of reticulocytes (HP:0004312) | 1.82315719 |
| 85 | Progressive macrocephaly (HP:0004481) | 1.80901318 |
| 86 | Focal motor seizures (HP:0011153) | 1.78795817 |
| 87 | Lactic acidosis (HP:0003128) | 1.77853456 |
| 88 | Abnormality of macular pigmentation (HP:0008002) | 1.73710748 |
| 89 | Generalized aminoaciduria (HP:0002909) | 1.73510700 |
| 90 | Triphalangeal thumb (HP:0001199) | 1.72246884 |
| 91 | Fasciculations (HP:0002380) | 1.71855749 |
| 92 | Pallor (HP:0000980) | 1.71682312 |
| 93 | Sclerocornea (HP:0000647) | 1.71499791 |
| 94 | Gliosis (HP:0002171) | 1.71286693 |
| 95 | Abolished electroretinogram (ERG) (HP:0000550) | 1.69446408 |
| 96 | CNS demyelination (HP:0007305) | 1.69377869 |
| 97 | Abnormality of the renal medulla (HP:0100957) | 1.68095083 |
| 98 | Short nail (HP:0001799) | 1.67869647 |
| 99 | Pulmonary fibrosis (HP:0002206) | 1.67292825 |
| 100 | Granulocytopenia (HP:0001913) | 1.67202263 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP4K2 | 5.11684624 |
| 2 | BCKDK | 4.43122507 |
| 3 | MAP3K12 | 3.65381242 |
| 4 | VRK2 | 3.59721308 |
| 5 | TAOK3 | 3.37911538 |
| 6 | MAP2K3 | 3.32466966 |
| 7 | MAP3K11 | 2.51965253 |
| 8 | ERN1 | 2.45374279 |
| 9 | PBK | 2.08821787 |
| 10 | MAP2K4 | 2.00207654 |
| 11 | NUAK1 | 1.93512981 |
| 12 | KIT | 1.90633426 |
| 13 | CCNB1 | 1.84661889 |
| 14 | MAP3K13 | 1.77455946 |
| 15 | MAP4K1 | 1.57327130 |
| 16 | MAP2K6 | 1.53923258 |
| 17 | STK16 | 1.50600158 |
| 18 | KDR | 1.46043940 |
| 19 | MAPK13 | 1.44630235 |
| 20 | GRK6 | 1.42387593 |
| 21 | FES | 1.42177177 |
| 22 | NME2 | 1.38469127 |
| 23 | ARAF | 1.37665602 |
| 24 | EPHA3 | 1.36639910 |
| 25 | MYLK | 1.22937697 |
| 26 | MAP3K6 | 1.19352748 |
| 27 | TESK2 | 1.17581921 |
| 28 | MATK | 1.17275328 |
| 29 | PIM2 | 1.15813136 |
| 30 | BMX | 1.09802437 |
| 31 | GRK5 | 1.08190223 |
| 32 | CSF1R | 1.08130330 |
| 33 | MST4 | 1.08065575 |
| 34 | FLT3 | 1.07521886 |
| 35 | CDK8 | 1.06631882 |
| 36 | VRK1 | 1.06332759 |
| 37 | DAPK1 | 1.05413862 |
| 38 | TEC | 1.05205835 |
| 39 | SYK | 1.03702333 |
| 40 | SRPK1 | 1.00578964 |
| 41 | MAP3K5 | 0.97115830 |
| 42 | BTK | 0.96712111 |
| 43 | LRRK2 | 0.95480154 |
| 44 | TRIM28 | 0.91506550 |
| 45 | PIK3CG | 0.89677409 |
| 46 | BMPR1B | 0.89174377 |
| 47 | ZAK | 0.88940974 |
| 48 | TAF1 | 0.88870324 |
| 49 | SCYL2 | 0.87493256 |
| 50 | DYRK2 | 0.87380644 |
| 51 | TIE1 | 0.83058507 |
| 52 | TBK1 | 0.77152008 |
| 53 | TLK1 | 0.76200745 |
| 54 | CDK19 | 0.75452483 |
| 55 | DYRK1B | 0.75139582 |
| 56 | PRKCQ | 0.75049025 |
| 57 | IKBKB | 0.74302168 |
| 58 | ATR | 0.74256629 |
| 59 | GRK7 | 0.72575600 |
| 60 | TESK1 | 0.71481532 |
| 61 | CSNK1G3 | 0.69961018 |
| 62 | ADRBK1 | 0.69030486 |
| 63 | ADRBK2 | 0.66573591 |
| 64 | INSRR | 0.64277073 |
| 65 | DAPK3 | 0.62650186 |
| 66 | RPS6KA5 | 0.56876573 |
| 67 | TNK2 | 0.56384222 |
| 68 | CSNK1G1 | 0.52936388 |
| 69 | ITK | 0.52322307 |
| 70 | PKN1 | 0.52105177 |
| 71 | DAPK2 | 0.50801785 |
| 72 | JAK3 | 0.46909860 |
| 73 | LMTK2 | 0.45999754 |
| 74 | BMPR2 | 0.45266914 |
| 75 | FER | 0.44622691 |
| 76 | WNK3 | 0.44547295 |
| 77 | AURKA | 0.41645225 |
| 78 | PINK1 | 0.41618285 |
| 79 | CAMK1 | 0.41370085 |
| 80 | PASK | 0.41023586 |
| 81 | LCK | 0.40250182 |
| 82 | PDK2 | 0.40001508 |
| 83 | TGFBR1 | 0.38879673 |
| 84 | PRKCA | 0.38693999 |
| 85 | MAP3K1 | 0.38683095 |
| 86 | LIMK1 | 0.37798555 |
| 87 | MOS | 0.36916903 |
| 88 | LYN | 0.34316584 |
| 89 | TXK | 0.33937593 |
| 90 | ILK | 0.33526924 |
| 91 | MKNK1 | 0.31308652 |
| 92 | CSNK1G2 | 0.30881177 |
| 93 | MAP2K7 | 0.30039130 |
| 94 | MAP3K7 | 0.29720016 |
| 95 | MAPK12 | 0.29489306 |
| 96 | CAMK2G | 0.28233246 |
| 97 | IGF1R | 0.27881763 |
| 98 | AKT2 | 0.26781097 |
| 99 | CSNK1A1L | 0.26765721 |
| 100 | GRK1 | 0.25912512 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 3.94611438 |
| 2 | Ribosome_Homo sapiens_hsa03010 | 3.79005061 |
| 3 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 3.60074129 |
| 4 | Parkinsons disease_Homo sapiens_hsa05012 | 3.28283721 |
| 5 | Base excision repair_Homo sapiens_hsa03410 | 2.83732869 |
| 6 | RNA polymerase_Homo sapiens_hsa03020 | 2.04206310 |
| 7 | Alzheimers disease_Homo sapiens_hsa05010 | 2.02185090 |
| 8 | Huntingtons disease_Homo sapiens_hsa05016 | 1.93401482 |
| 9 | Proteasome_Homo sapiens_hsa03050 | 1.90823591 |
| 10 | Asthma_Homo sapiens_hsa05310 | 1.81716522 |
| 11 | Peroxisome_Homo sapiens_hsa04146 | 1.79592624 |
| 12 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.76748047 |
| 13 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.69009844 |
| 14 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.61945481 |
| 15 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 1.60696753 |
| 16 | Allograft rejection_Homo sapiens_hsa05330 | 1.59517880 |
| 17 | Phototransduction_Homo sapiens_hsa04744 | 1.57832101 |
| 18 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.55482933 |
| 19 | Platelet activation_Homo sapiens_hsa04611 | 1.55205033 |
| 20 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.49664862 |
| 21 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.49264403 |
| 22 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.49015992 |
| 23 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.48768891 |
| 24 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.46116587 |
| 25 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.44301422 |
| 26 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 1.42986898 |
| 27 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 1.41356972 |
| 28 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.41319723 |
| 29 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.37089579 |
| 30 | Purine metabolism_Homo sapiens_hsa00230 | 1.36697725 |
| 31 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.35145724 |
| 32 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.29346223 |
| 33 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.24502818 |
| 34 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.22524652 |
| 35 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.16183590 |
| 36 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.12856231 |
| 37 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.10146558 |
| 38 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.06498757 |
| 39 | Protein export_Homo sapiens_hsa03060 | 1.04466312 |
| 40 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.02079463 |
| 41 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.00165161 |
| 42 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.99957513 |
| 43 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.98974396 |
| 44 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.97786447 |
| 45 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.97425023 |
| 46 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.95985115 |
| 47 | Olfactory transduction_Homo sapiens_hsa04740 | 0.94176777 |
| 48 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.93244584 |
| 49 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.90330376 |
| 50 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.89933673 |
| 51 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.86527793 |
| 52 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.86173073 |
| 53 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.85190099 |
| 54 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.84714832 |
| 55 | Mismatch repair_Homo sapiens_hsa03430 | 0.83954365 |
| 56 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.83713227 |
| 57 | Metabolic pathways_Homo sapiens_hsa01100 | 0.83577668 |
| 58 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.80767356 |
| 59 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.80519188 |
| 60 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.77905884 |
| 61 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.76857934 |
| 62 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.75080616 |
| 63 | DNA replication_Homo sapiens_hsa03030 | 0.73890090 |
| 64 | Homologous recombination_Homo sapiens_hsa03440 | 0.73184045 |
| 65 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.70340619 |
| 66 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.70172260 |
| 67 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.69901783 |
| 68 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.68826277 |
| 69 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.68546226 |
| 70 | Taste transduction_Homo sapiens_hsa04742 | 0.66386128 |
| 71 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.65142607 |
| 72 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.62976398 |
| 73 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.60770501 |
| 74 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.60579037 |
| 75 | Carbon metabolism_Homo sapiens_hsa01200 | 0.59984479 |
| 76 | Sulfur relay system_Homo sapiens_hsa04122 | 0.59340510 |
| 77 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.58959018 |
| 78 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.56594668 |
| 79 | Circadian entrainment_Homo sapiens_hsa04713 | 0.53224703 |
| 80 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.51519716 |
| 81 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.49064131 |
| 82 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.47512052 |
| 83 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.47441247 |
| 84 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.46664497 |
| 85 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.46198458 |
| 86 | RNA degradation_Homo sapiens_hsa03018 | 0.43923305 |
| 87 | Nicotine addiction_Homo sapiens_hsa05033 | 0.43696021 |
| 88 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.43691282 |
| 89 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.43612918 |
| 90 | Pertussis_Homo sapiens_hsa05133 | 0.42123306 |
| 91 | Salivary secretion_Homo sapiens_hsa04970 | 0.41669787 |
| 92 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.39470852 |
| 93 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.38228124 |
| 94 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.37138193 |
| 95 | Cocaine addiction_Homo sapiens_hsa05030 | 0.36430150 |
| 96 | Galactose metabolism_Homo sapiens_hsa00052 | 0.36276821 |
| 97 | Renin secretion_Homo sapiens_hsa04924 | 0.34223220 |
| 98 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.31564524 |
| 99 | Lysosome_Homo sapiens_hsa04142 | 0.30302959 |
| 100 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.30253136 |

